Antibiotics for exacerbations of chronic obstructive pulmonary disease
about
Exacerbations of COPDWhen should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelinesReal-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.PURLs: Should you consider antibiotics for exacerbations of mild COPD?Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data.The role of the microbiome in exacerbations of chronic lung diseases.Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.Implementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutions.Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbationsStandards of suitability for the management of chronic obstructive respiratory diseasesRandomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.Influence of lung function on course of disease and response to antibiotic therapy in adult primary care patients with acute cough: a post hoc analysis of patients enrolled in a prospective multicentre study.Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD AuditThe bacterial microbiota in inflammatory lung diseasesTrends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation.Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trialGuidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study.Respiratory viruses in acute exacerbations of chronic obstructive pulmonary disease.The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.Relationship Between Severity Classification of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Clinical Outcomes in Hospitalized Patients.Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilmsPredicting Healthcare Utilization by Patients Admitted for COPD Exacerbation.Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD.General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled triaAcute exacerbated COPD: room for improvement in key elements of care.Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review.Do not do in COPD: consensus statement on overuse.Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care.Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.Diagnostic use of lung ultrasound compared to chest radiograph for suspected pneumonia in a resource-limited setting.Antibiotics for COPD exacerbations.Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.Management of severe acute exacerbations of COPD: an updated narrative reviewThe Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
P2860
Q26764891-E6D02CC4-C1BB-49AA-B304-926B9D2D9FDEQ28085429-D1EBBEF4-DF6D-44C7-8611-E26227F50852Q31158516-DCAC410B-DD49-4ED9-8F3A-6DDC128850B7Q33703968-3EA5499E-19EE-4B3A-BE42-09F91E751AE3Q33819984-71F39EA5-35D1-4172-B00F-467B0C7B3715Q34199591-C7DB0E6E-6EAD-4B18-9FCC-5B395345A26FQ34547587-E738F7E8-D962-486E-B4E1-A6BD5ACF80A9Q34628637-EAC1A915-AB0F-46DB-AD37-72A7BD1B4AD5Q34799593-61E04C3E-4E2F-4357-AB2C-F73763E6B0B9Q34911219-BBAD2D6C-4C03-4372-93E6-CAE178491806Q35149431-54A948F5-6A0C-4DBD-980A-DB13636438BFQ35168487-46A645EF-0EAF-4105-A7C6-2EF74BA94F6EQ35216370-AEEAD1AF-B84B-4E19-B07E-4DFB1D222D74Q35533063-DEDB6DC8-0CF9-45F7-BD4E-8D7D5B1893BCQ35677622-A72E3103-3E25-4A8B-A81C-4769559BB9ECQ36113688-CDD3E18D-FAD7-427C-855F-B57AB4B26D72Q36426923-C854B000-9681-4692-B20D-E7CB6A1E2595Q37085594-0321BF8F-C6B1-4894-8C2B-8B808F9BEC02Q37177278-3704C326-73CD-42B0-B4BE-AC9F016FABA9Q37496448-8AB661EE-2555-4002-B2DC-B1231C80FECFQ37584970-79645ED8-711E-4E07-9634-3186908CFAFBQ38853672-19548173-3B88-4A9A-BE29-FB313D6FDE42Q38925964-9978B28B-DC3F-494F-B13B-16F8B81DB4A0Q39167799-93E891C7-1805-4E19-AC5B-809738083ACBQ39246070-A080E135-489D-4DDD-A6D8-E2D7446680CCQ40448715-EA28441F-822A-4738-8325-FCAFDC0C6B45Q41028419-0DEEC5CC-01D9-4C6A-93B1-997EE8F214D0Q42172274-3B1E1133-FA3D-4823-9082-C553D4BAC9DDQ42688268-C1C773CE-F1E8-4664-9098-A79EBDF5E0FFQ47127548-F20D3972-0DCD-4B60-95AC-A1A53F68035DQ47682718-6E84278E-6DFA-4B02-BD0D-DAA6428A1C97Q49625748-78B41A6E-0DEA-4B0D-B2D4-4478D53FC4DAQ51784702-75D74E8E-FCE3-49BE-9945-081BE048009DQ53070303-C648A727-0895-4B6E-A771-03D699552501Q55001367-1D60DB82-B072-41BA-8556-139046A211F7Q55234652-C5902A79-DB29-4558-A5C7-F1F7A64ED3B1Q55262081-2A1709BA-B6FA-4124-BFEC-ABFF04B2AFAFQ55400934-667A39D3-6C9B-477F-8495-D5D068508ADDQ57298307-F01D015B-2E03-45EF-936E-B41D586FC447Q59130095-4CB4AD5D-121B-4D1A-812C-FE9973073D9F
P2860
Antibiotics for exacerbations of chronic obstructive pulmonary disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@ast
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en-gb
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@nl
type
label
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@ast
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en-gb
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@nl
prefLabel
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@ast
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en-gb
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@nl
P2093
P2860
P1476
Antibiotics for exacerbations of chronic obstructive pulmonary disease
@en
P2093
Claudia A Steurer-Stey
Daniela J Vollenweider
Harish Jarrett
Milo A Puhan
P2860
P356
10.1002/14651858.CD010257
P577
2012-12-12T00:00:00Z